ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,559, issued on Feb. 17, was assigned to RAMBAM MED-TECH LTD. (Haifa, Israel) and TECHNION RESEARCH & DEVELOPMENT FOUNDATION Ltd. (Haifa, Israel).

"Cells and methods for improved immunotherapy" was invented by Igal Louria-Hayon (Atlit, Israel), Yishai Ofran (Hoshaya, Israel), Michal Hayun (Yokneam, Israel) and Yael Derdikman Ofir (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Cells comprising an exogenous protein and decreased SH2B adapter protein 3 (SH2B3) protein expression and/or function are provided. Pharmaceutical compositions comprising the cells of the invention as well as methods of treating a disease in a subject in need ther...